Sessa Capital (Master), L.P.
Insider CIK 1618360 · PRVB 10% owner · GTX Director, 10% owner · SABS Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| SABS SAB Biotherapeutics, Inc. | M Exercise deriv | 2025-09-29 | 2025-10-01 | 17,400 | — | $0 | 211,100 | SEC↗ |
| SABS SAB Biotherapeutics, Inc. | M Exercise | 2025-09-29 | 2025-10-01 | 1,740,000 | $1.75 | $3.04M | 2,198,457 | SEC↗ |
| SABS SAB Biotherapeutics, Inc. | A Award deriv | 2025-07-22 | 2025-07-24 | 228,500 | — | $0 | 228,500 | SEC↗ |
| SABS SAB Biotherapeutics, Inc. | A Award deriv | 2025-07-22 | 2025-07-24 | 228,500 | — | $0 | 228,500 | SEC↗ |
| SABS SAB Biotherapeutics, Inc. | A Award deriv | 2025-07-22 | 2025-07-24 | 114,250 | — | $0 | 114,250 | SEC↗ |
| GTX Garrett Motion Inc. | S Sale | 2024-03-06 | 2024-03-06 | 10,000,000 | $9.00 | $90.00M | 15,236,484 | SEC↗ |
| SABS SAB Biotherapeutics, Inc. | M Exercise deriv | 2023-11-24 | 2023-11-28 | 31,269 | $1000.00 | $31.27M | 0 | SEC↗ |
| SABS SAB Biotherapeutics, Inc. | M Exercise deriv | 2023-11-24 | 2023-11-28 | 28,380 | $1000.00 | $28.38M | 28,380 | SEC↗ |
| SABS SAB Biotherapeutics, Inc. | M Exercise | 2023-11-24 | 2023-11-28 | 4,584,571 | — | $0 | 4,584,571 | SEC↗ |
| SABS SAB Biotherapeutics, Inc. | A Award deriv | 2023-11-13 | 2023-11-14 | 13,269 | $1000.00 | $13.27M | 31,269 | SEC↗ |
| SABS SAB Biotherapeutics, Inc. | M Exercise deriv | 2023-11-13 | 2023-11-14 | 13,269 | — | $0 | 0 | SEC↗ |
| SABS SAB Biotherapeutics, Inc. | A Award deriv | 2023-11-13 | 2023-11-15 | 13,269 | $1000.00 | $13.27M | 31,269 | SEC↗ |
| SABS SAB Biotherapeutics, Inc. | A Award deriv | 2023-11-10 | 2023-11-14 | 22,115 | — | $0 | 52,115 | SEC↗ |
| SABS SAB Biotherapeutics, Inc. | A Award deriv | 2023-11-10 | 2023-11-14 | 8,846 | — | $0 | 20,846 | SEC↗ |
| SABS SAB Biotherapeutics, Inc. | A Award deriv | 2023-11-10 | 2023-11-14 | 13,269 | — | $0 | 13,269 | SEC↗ |
| SABS SAB Biotherapeutics, Inc. | A Award deriv | 2023-10-23 | 2023-10-24 | 16,269 | $1000.00 | $16.27M | 18,000 | SEC↗ |
| SABS SAB Biotherapeutics, Inc. | M Exercise deriv | 2023-10-23 | 2023-10-24 | 16,269 | — | $0 | 0 | SEC↗ |
| GTX Garrett Motion Inc. | M Exercise | 2023-06-13 | 2023-06-14 | 1,731,896 | — | $0 | 25,236,484 | SEC↗ |
| GTX Garrett Motion Inc. | M Exercise deriv | 2023-06-06 | 2023-06-08 | 16,592,384 | — | $0 | 0 | SEC↗ |
| GTX Garrett Motion Inc. | M Exercise | 2023-06-06 | 2023-06-08 | 16,592,384 | — | $0 | 23,504,588 | SEC↗ |
| PRVB Provention Bio, Inc. | U Tender | 2023-04-27 | 2023-04-28 | 15,567,497 | — | $0 | 0 | SEC↗ |
| PRVB Provention Bio, Inc. | G Gift | 2023-04-21 | 2023-04-24 | 224,617 | — | $0 | 0 | SEC↗ |
| PRVB Provention Bio, Inc. | G Gift | 2023-04-20 | 2023-04-24 | 202,314 | — | $0 | 224,617 | SEC↗ |
| PRVB Provention Bio, Inc. | X Exercise deriv | 2023-04-14 | 2023-04-18 | 8,879,023 | — | $0 | 0 | SEC↗ |
| PRVB Provention Bio, Inc. | X Exercise | 2023-04-14 | 2023-04-18 | 8,879,023 | $6.00 | $53.27M | 17,758,046 | SEC↗ |
| PRVB Provention Bio, Inc. | S Sale | 2023-04-14 | 2023-04-18 | 2,190,549 | $24.32 | $53.27M | 15,567,497 | SEC↗ |
| PRVB Provention Bio, Inc. | G Gift | 2023-04-04 | 2023-04-04 | 218,651 | — | $0 | 426,931 | SEC↗ |
| PRVB Provention Bio, Inc. | J Other | 2023-03-31 | 2023-04-04 | 3,000,000 | — | $0 | 8,879,023 | SEC↗ |
| PRVB Provention Bio, Inc. | S Sale | 2023-01-18 | 2023-01-20 | 3,000,000 | $9.40 | $28.20M | 11,879,023 | SEC↗ |
| GTX Garrett Motion Inc. | P Buy deriv | 2021-05-07 | 2021-05-10 | 380,952 | $5.25 | $2.00M | 16,592,384 | SEC↗ |
| GTX Garrett Motion Inc. | J Other | 2021-04-30 | 2021-05-03 | 6,912,204 | — | $0 | 0 | SEC↗ |